AbbVie Inc.
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$288.84−6.05 (-2.05%)
Close on Nov 2, 2026Market cap $510.41BP/E 81.6Yield 2.30%
AbbVie Common Stock Held in Treasury (M shares): 70.80 m_shares in FY2025, up 6.8% from a year earlier.
Latest, FY2025
70.80
Period ended Dec 31, 2025
Change on a year earlier
+6.8%
66.30 in FY2024
History
11 years
Since FY2015
Sources
11
Documents cited below
Where the FY2025 figure comes from
Source: Form 10-Q (filed 2026-08-03) ↗
Reported in Form 10-Q / 10-K Consolidated Balance Sheets.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Common Stock Held in Treasury (M shares) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 70.80 | +6.8% | Form 10-Q (filed 2026-08-03) ↗ |
| FY2024 | Dec 31, 2024 | 66.30 | +16.1% | Form 10-K (filed 2026-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 57.10 | +28.0% | Form 10-K (filed 2025-02-14) ↗ |
| FY2022 | Dec 31, 2022 | 44.60 | +27.8% | Form 10-K (filed 2024-02-20) ↗ |
| FY2021 | Dec 31, 2021 | 34.90 | +29.3% | Form 10-K (filed 2023-02-17) ↗ |
| FY2020 | Dec 31, 2020 | 27.00 | -91.1% | Form 10-K (filed 2022-02-18) ↗ |
| FY2019 | Dec 31, 2019 | 302.70 | +1.7% | Form 10-K (filed 2021-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 297.70 | +68.6% | Form 10-K (filed 2020-02-21) ↗ |
| FY2017 | Dec 31, 2017 | 176.60 | +8.7% | Form 10-K (filed 2019-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 162.40 | +16.8% | Form 10-K (filed 2018-02-16) ↗ |
| FY2015 | Dec 31, 2015 | 139.10 | – | Form 10-K (filed 2017-02-17) ↗ |
Cite this data
StockData. (2026). AbbVie Common Stock Held in Treasury (M shares), annual FY2015–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/cap-treasury-sh
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.